Skip to main content
. 2014 Apr 28;8:40. doi: 10.3389/fncir.2014.00040

Table 2.

Antibodies used in the study.

Primary antibody combination Primary antibody concentration Supplier Secondary antibodies
A gt. CTb 1:5000 List Biological Laboratories, Campell, CA Rh.Red
rbt FG 1:5000 Chemicon/Millipore,CA,USA Alexa488
B mo. CTb 1:250 A. Wikström, University of Gothenburg Rh.Red
gp VGLUT1 1:5000 Millipore, Harlow, UK Alexa488
gp VGLUT2 1:5000 Millipore, Harlow, UK Dylight 649
C mo. CTb 1:250 A. Wikström, University of Gothenburg Rh.Red
rbt VGAT 1:1000 Synaptic System, Göttingen, Germany Alexa488
gp VGLUT1 1:5000 Millipore, Harlow, UK Dylight 649
gp VGLUT2 1:5000 Millipore, Harlow, UK Dylight 649
D gt. CTb 1:5000 List Biological Laboratories, Campell, CA Rh.Red
rbt GLYT2 1:1000 Millipore, Harlow, UK Alexa488
mo GAD67 1:1000 Millipore, Harlow, UK Dylight 649
E mo. CTb 1:250 A. Wikström, University of Gothenburg Rh.Red
rbt Serotonin 1:100 Affiniti, Exeter, UK Alexa488

gt, goat; rbt, rabbit; mo, mouse; gp, guinea pig; FG, Fluorogold; CTb, the b subunit of cholera toxin; VGLUT1, vesicular glutamate transporter 1; VGLUT2, vesicular glutamate transporter 2; VGAT, vesicular GABA transporter; GLYT2, glycine transporter 2; GAD67, 67 isoform of glutamate decarboxylase. In Experiment C tissue was incubated in a mixture of VGLUT1+2 antibodies.